A detailed history of Point Break Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Point Break Capital Management, LLC holds 4,221 shares of LLY stock, worth $3.36 Million. This represents 4.39% of its overall portfolio holdings.

Number of Shares
4,221
Previous 4,401 4.09%
Holding current value
$3.36 Million
Previous $3.98 Million 6.15%
% of portfolio
4.39%
Previous 4.33%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $138,985 - $172,803
-180 Reduced 4.09%
4,221 $3.74 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $1.45 Million - $1.82 Million
2,000 Added 83.3%
4,401 $3.98 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $613,519 - $820,802
1,036 Added 75.9%
2,401 $1.87 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $716,884 - $845,112
1,365 New
1,365 $795,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Point Break Capital Management, LLC Portfolio

Follow Point Break Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point Break Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Point Break Capital Management, LLC with notifications on news.